Patent details

EP2891658 Title: TENOFOVIR PRODRUG AND PHARMACEUTICAL USES THEREOF

Basic Information

Publication number:
EP2891658
PCT Application Number:
CN2013079123
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP138322276
PCT Publication Number:
WO2014032481
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TENOFOVIR PRODRUG AND PHARMACEUTICAL USES THEREOF
French Title of Invention:
PROMÉDICAMENT DU TÉNOFOVIR ET UTILISATIONS PHARMACEUTIQUES ASSOCIÉES
German Title of Invention:
TENOFOVIR-PRODRUG UND PHARMAZEUTISCHE VERWENDUNGEN DAVON
SPC Number:

Dates

Filing date:
10/07/2013
Grant date:
31/05/2017
EP Publication Date:
08/07/2015
PCT Publication Date:
06/03/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
31/05/2017
EP B1 Publication Date:
31/05/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
10/07/2017
Expiration date:
10/07/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
31/05/2017
 
 

Name:
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Address:
The 10th Industrial Sub-Zone of Development Zone Lianyungang, Jiangsu Province 222047, China (CN)

Inventor

1

Name:
WEI, Dong
Address:
China (CN)

2

Name:
ZHANG, Fuyao
Address:
China (CN)

Priority

1

Priority Number:
201210315565
Priority Date:
30/08/2012
Priority Country:
China (CN)

2

Priority Number:
201310041647
Priority Date:
01/02/2013
Priority Country:
China (CN)

Classification

IPC classification:
A61K 31/675; A61P 31/12; C07F 9/6561;

Publication

European Patent Bulletin

Issue number:
201722
Publication date:
31/05/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/11/2017 Outgoing Correspondence 2